SG Stock MarketDetailed Quotes

HQXW IX BiopharmaW260718

Watchlist

0.003
0.0000.00%

10min DelayTrading Jul 25 09:15 CST

2.30MMarket Cap0.00P/E (TTM)

IX BiopharmaW260718 Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(Q2)Dec 31, 2019

(Q1)Sep 30, 2019

Total revenue

-58.91%5.91M

724.64%14.39M

77.16%1.75M

985K

174K

120K

Cost of revenue

71.10%3.59M

-1.27%2.1M

35.31%2.13M

1.57M

334K

355K

Gross profit

-81.12%2.32M

3,317.28%12.29M

34.92%-382K

-587K

-160K

-235K

Operating expense

-2.60%10.73M

14.19%11.02M

-7.39%9.65M

10.42M

2.58M

2.5M

Selling and administrative expenses

-4.37%9.04M

13.94%9.46M

-3.54%8.3M

--8.61M

--2.28M

--2.01M

-Selling and marketing expense

52.96%3.17M

-7.74%2.08M

-0.44%2.25M

--2.26M

--543K

--648K

-General and administrative expense

-20.48%5.87M

22.00%7.38M

-4.65%6.05M

--6.35M

--1.73M

--1.36M

Research and development costs

20.93%2.82M

-15.11%2.33M

9.92%2.75M

--2.5M

--522K

--715K

Total other operating income

46.76%1.13M

-44.82%772K

103.94%1.4M

--686K

--219K

Operating profit

-760.72%-8.41M

112.69%1.27M

8.86%-10.03M

-11.01M

-2.74M

Net non-operating interest income expense

-30.69%-264K

-20.96%-202K

-10.60%-167K

-151K

-57K

-62K

Non-operating interest income

--7K

--0

-91.95%7K

--87K

----

Non-operating interest expense

34.16%271K

16.09%202K

-26.89%174K

--238K

--57K

--62K

Net investment income

-45.11%-2.77M

-206.46%-1.91M

367.45%1.8M

384K

Gain/Loss on financial instruments designated as cash flow hedges

Gain/Loss on derecognition of available-for-sale financial assets

153.45%1.74M

-3.26M

Income from associates and other participating interests

Special income /charges

Other non-operating income /expenses

-38.10%169K

273K

376K

-544K

Income before tax

-136.79%-9.71M

50.21%-4.1M

21.58%-8.23M

-10.5M

-2.42M

-3.35M

Income tax

-118.24%-91K

49,800.00%499K

Net income

-109.11%-9.62M

44.16%-4.6M

21.57%-8.23M

-10.5M

-2.42M

-3.35M

Net income continuous operations

-109.11%-9.62M

44.16%-4.6M

21.57%-8.23M

---10.5M

---2.42M

---3.35M

Net income discontinuous operations

----

--0

Noncontrolling interests

Net income attributable to the company

-109.11%-9.62M

44.16%-4.6M

21.57%-8.23M

-10.5M

-2.42M

-3.35M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-109.11%-9.62M

44.16%-4.6M

21.57%-8.23M

-10.5M

-2.42M

-3.35M

Gross dividend payment

Basic earnings per share

Diluted earnings per share

Dividend per share

Currency Unit

SGD

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(Q2)Dec 31, 2019	(Q1)Sep 30, 2019
Total revenue	-58.91%5.91M	724.64%14.39M	77.16%1.75M	985K	174K	120K
Cost of revenue	71.10%3.59M	-1.27%2.1M	35.31%2.13M	1.57M	334K	355K
Gross profit	-81.12%2.32M	3,317.28%12.29M	34.92%-382K	-587K	-160K	-235K
Operating expense	-2.60%10.73M	14.19%11.02M	-7.39%9.65M	10.42M	2.58M	2.5M
Selling and administrative expenses	-4.37%9.04M	13.94%9.46M	-3.54%8.3M	--8.61M	--2.28M	--2.01M
-Selling and marketing expense	52.96%3.17M	-7.74%2.08M	-0.44%2.25M	--2.26M	--543K	--648K
-General and administrative expense	-20.48%5.87M	22.00%7.38M	-4.65%6.05M	--6.35M	--1.73M	--1.36M
Research and development costs	20.93%2.82M	-15.11%2.33M	9.92%2.75M	--2.5M	--522K	--715K
Total other operating income	46.76%1.13M	-44.82%772K	103.94%1.4M	--686K	--219K	--219K
Operating profit	-760.72%-8.41M	112.69%1.27M	8.86%-10.03M	-11.01M	-2.74M	-2.74M
Net non-operating interest income expense	-30.69%-264K	-20.96%-202K	-10.60%-167K	-151K	-57K	-62K
Non-operating interest income	--7K	--0	-91.95%7K	--87K	----	----
Non-operating interest expense	34.16%271K	16.09%202K	-26.89%174K	--238K	--57K	--62K
Net investment income	-45.11%-2.77M	-206.46%-1.91M	367.45%1.8M	384K
Gain/Loss on financial instruments designated as cash flow hedges
Gain/Loss on derecognition of available-for-sale financial assets	153.45%1.74M	-3.26M	0
Income from associates and other participating interests
Special income /charges
Other non-operating income /expenses			-38.10%169K	273K	376K	-544K
Income before tax	-136.79%-9.71M	50.21%-4.1M	21.58%-8.23M	-10.5M	-2.42M	-3.35M
Income tax	-118.24%-91K	49,800.00%499K	1K	0	0	0
Net income	-109.11%-9.62M	44.16%-4.6M	21.57%-8.23M	-10.5M	-2.42M	-3.35M
Net income continuous operations	-109.11%-9.62M	44.16%-4.6M	21.57%-8.23M	---10.5M	---2.42M	---3.35M
Net income discontinuous operations	----	----	----	----	--0	--0
Noncontrolling interests
Net income attributable to the company	-109.11%-9.62M	44.16%-4.6M	21.57%-8.23M	-10.5M	-2.42M	-3.35M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0
Net income attributable to common stockholders	-109.11%-9.62M	44.16%-4.6M	21.57%-8.23M	-10.5M	-2.42M	-3.35M
Gross dividend payment
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit	SGD	SGD	SGD	SGD	SGD	SGD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall